PATENT CLAIM ANALYSIS

Application Number: 16070150
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "133100"]

Abstract:
Methods of treating Alzheimer's Disease (AD) in patients suffering from early AD, including amyloid positive patients, ApoE4 positive patients, and patients suffering from prodromal or mild AD are provided.

Claim (Index 16):
The method of  claim 13  or  14 , wherein the antibody is administered via intravenous injection.

Metadata:
- Claim Count in Document: 86.0
- Percentile: 95.0
- Lexical Diversity: 1.38462
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14283038', '14292461', '13292633', '15234649', '12738396']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.4143206290773537
- 35 USC 102 Novelty (BERT): 0.5305429676469484
- Combined Prediction Score: 0.4259428629343132
- Mean Citation Score: 293.24531599999995
- Max Citation Score: 302.40604
- Similarity Product: 201.8046667748499

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test